West Pharmaceutical Services Inc. buy UBS Group AG
Start price
25.07.25
/
50%
€226.50
Target price
25.07.26
€272.54
Performance (%)
-7.02%
Price
05.03.26
€210.60
Summary
This prediction is currently active. With a performance of -7.02%, the BUY prediction for West Pharmaceutical Services Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 25.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| West Pharmaceutical Services Inc. | 1.056% | 1.056% |
| iShares Core DAX® | -6.016% | -4.595% |
| iShares Nasdaq 100 | 0.511% | 0.164% |
| iShares Nikkei 225® | -7.156% | -2.215% |
| iShares S&P 500 | -0.257% | -0.841% |
Comments by UBS_Group_AG for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€208.70
13.02.26
13.02.26
-
13.02.27
13.02.27
0.91%
05.03.26
05.03.26
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€310.00
12.12.24
12.12.24
€372.22
12.12.25
12.12.25
-27.03%
13.12.25
13.12.25